Literature DB >> 19188396

Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Sara Thulin Hedberg1, Hans Fredlund, Pierre Nicolas, Dominique A Caugant, Per Olcén, Magnus Unemo.   

Abstract

Up-to-date information regarding the antibiotic susceptibility of Neisseria meningitidis strains from African countries is highly limited. Our aim was to comprehensively describe the antibiotic susceptibilities of a selection of N. meningitidis isolates recovered between 2000 and 2006 from 18 African countries, mainly those within the meningitis belt. Susceptibilities to 11 antibiotics were determined using Etest for 137 N. meningitidis isolates (stringently selected from 693 available isolates). The isolates were also characterized by serogrouping, multilocus sequence typing, genosubtyping, and penA allele identification. All N. meningitidis isolates were susceptible to ceftriaxone, chloramphenicol, and ciprofloxacin. No isolate produced beta-lactamase. Only three isolates (2%) displayed reduced susceptibility to penicillin G. The two isolates with the highest penicillin G MICs were the only isolates showing reduced susceptibility to ampicillin and cefuroxime. One of these isolates was also resistant to penicillin V. One percent of isolates displayed reduced susceptibility to rifampin, while 52% of the isolates were resistant to tetracycline, 74% were resistant to erythromycin, and 94% were resistant to sulfadiazine. The MICs of rifampin and tetracycline seemed to be associated with the serogroup of the isolates. In total, 18 sequence types (STs), 10 genosubtypes, and 8 different penA alleles were identified; the most common were ST-7, P1.20,9,35-1, and penA4, respectively. A high level of correlation was found between ST, genosubtype, and penA allele. In conclusion, N. meningitidis isolates from the African meningitis belt remain highly susceptible to the antibiotics used. Regarding beta-lactam antibiotics, rare isolates showed a reduced susceptibility to penicillins, but the expanded-spectrum cephalosporins are not affected at present.

Entities:  

Mesh:

Year:  2009        PMID: 19188396      PMCID: PMC2663058          DOI: 10.1128/AAC.00994-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina.

Authors:  Alejandra Corso; Diego Faccone; Mariana Miranda; Marisa Rodriguez; Mabel Regueira; Cristina Carranza; Cecilia Vencina; Julio A Vazquez; Marcelo Galas
Journal:  J Antimicrob Chemother       Date:  2005-02-22       Impact factor: 5.790

2.  International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to tet(B).

Authors:  Sharon A Crawford; Kristin R Fiebelkorn; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India.

Authors:  Vikas Manchanda; P Bhalla
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

Review 4.  Meningitis epidemics in Africa: a brief overview.

Authors:  Rémy Teyssou; Erwan Muros-Le Rouzic
Journal:  Vaccine       Date:  2007-05-15       Impact factor: 3.641

5.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment.

Authors:  Y Van de Peer; R De Wachter
Journal:  Comput Appl Biosci       Date:  1994-09

7.  Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana.

Authors:  S Gagneux; A Hodgson; I Ehrhard; G Morelli; B Genton; T Smith; M Tanner; F Binka; M Achtman; G Pluschke
Journal:  Trop Med Int Health       Date:  2000-04       Impact factor: 2.622

Review 8.  Antibiotic resistance in Neisseria meningitidis.

Authors:  B A Oppenheim
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

9.  High-level chloramphenicol resistance in Neisseria meningitidis.

Authors:  M Galimand; G Gerbaud; M Guibourdenche; J Y Riou; P Courvalin
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

10.  Ciprofloxacin resistance in Neisseria meningitidis, France.

Authors:  Anna Skoczynska; Jean-Michel Alonso; Muhamed-Kheir Taha
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  13 in total

1.  Management of a rifampicin-resistant meningococcal infection in a teenager.

Authors:  D Delaune; D Andriamanantena; A Mérens; E Viant; O Aoun; F Ceppa; M-K Taha; C Rapp
Journal:  Infection       Date:  2013-02-14       Impact factor: 3.553

Review 2.  Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries.

Authors:  Elizabeth A Ashley; Yoel Lubell; Nicholas J White; Paul Turner
Journal:  Trop Med Int Health       Date:  2011-06-24       Impact factor: 2.622

Review 3.  Rise of the microbes.

Authors:  Michael J Mahan; Jessica Z Kubicek-Sutherland; Douglas M Heithoff
Journal:  Virulence       Date:  2013-01-18       Impact factor: 5.882

4.  Neisseria meningitidis Antimicrobial Resistance in Italy, 2006 to 2016.

Authors:  Paola Vacca; Cecilia Fazio; Arianna Neri; Luigina Ambrosio; Annapina Palmieri; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 5.  Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review.

Authors:  Fataneh Hashempour-Baltork; Hedayat Hosseini; Saeedeh Shojaee-Aliabadi; Mohammadali Torbati; Adel Mirza Alizadeh; Matin Alizadeh
Journal:  Adv Pharm Bull       Date:  2019-08-01

6.  The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia.

Authors:  Elizabeth M Batty; Tomas-Paul Cusack; Janjira Thaipadungpanit; Wanitda Watthanaworawit; Verena Carrara; Somsavanh Sihalath; Jill Hopkins; Sona Soeng; Clare Ling; Paul Turner; David A B Dance
Journal:  Int J Infect Dis       Date:  2020-04-08       Impact factor: 3.623

7.  Imported ciprofloxacin-resistant Neisseria meningitidis.

Authors:  Giuseppe Lapadula; Franco Viganò; Paolo Fortuna; Alberto Dolara; Simone Bramati; Alessandro Soria; Sergio Foresti; Andrea Gori
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

8.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

9.  Central nervous system infections in travelers.

Authors:  H L Kirsch; K T Thakur; G L Birbeck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

Review 10.  Meningitis in HIV-positive patients in sub-Saharan Africa: a review.

Authors:  Jennifer A Veltman; Claire C Bristow; Jeffrey D Klausner
Journal:  J Int AIDS Soc       Date:  2014-10-10       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.